India, June 11 -- Shares of Glenmark Pharmaceuticals Limited are likely to remain in focus after the company announced the launch of Winlevi (clascoterone 10 mg/g cream) across key European markets, marking a significant milestone in its specialty dermatology business.

Glenmark Pharmaceuticals Limited has a total market capitalization of approximately Rs. 60,966.66 crore. The company's shares were trading at Rs. 2160.10 apiece on the stock exchange, up by 0.73 percent during the session. The stock has declined around 0.93 percent over the last five trading sessions. The stock has declined around 7.96 percent over the last month, reflecting negative momentum. The stock touched a 52-week high of Rs. 2474 and a 52-week low of Rs. 1589.

Gle...